BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 36096973)

  • 1. Comparison of global treatment guidelines for locally advanced cervical cancer to optimize best care practices: A systematic and scoping review.
    Pujade-Lauraine E; Tan DSP; Leary A; Mirza MR; Enomoto T; Takyar J; Nunes AT; Chagüi JDH; Paskow MJ; Monk BJ
    Gynecol Oncol; 2022 Nov; 167(2):360-372. PubMed ID: 36096973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2015 Apr; (4):CD010260. PubMed ID: 25847525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography/computerised tomography imaging in detecting and managing recurrent cervical cancer: systematic review of evidence, elicitation of subjective probabilities and economic modelling.
    Meads C; Auguste P; Davenport C; Małysiak S; Sundar S; Kowalska M; Zapalska A; Guest P; Thangaratinam S; Martin-Hirsch P; Borowiack E; Barton P; Roberts T; Khan K
    Health Technol Assess; 2013 Mar; 17(12):1-323. PubMed ID: 23537558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hysterectomy with radiotherapy or chemotherapy or both for women with locally advanced cervical cancer.
    Kokka F; Bryant A; Olaitan A; Brockbank E; Powell M; Oram D
    Cochrane Database Syst Rev; 2022 Aug; 8(8):CD010260. PubMed ID: 35994243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study.
    Marnitz S; Tsunoda AT; Martus P; Vieira M; Affonso Junior RJ; Nunes J; Budach V; Hertel H; Mustea A; Sehouli J; Scharf JP; Ulrich U; Ebert A; Piwonski I; Kohler C
    Int J Gynecol Cancer; 2020 Dec; 30(12):1855-1861. PubMed ID: 33293284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of ultrasound in primary workup of cervical cancer staging (ESGO, ESTRO, ESP cervical cancer guidelines).
    Fischerová D; Cibula D
    Ceska Gynekol; 2019; 84(1):40-48. PubMed ID: 31213057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncologic outcomes in the era of modern radiation therapy using FIGO 2018 staging system for cervical cancer.
    Brodeur MN; Dejean R; Beauchemin MC; Samouëlian V; Cormier B; Bacha OM; Warkus T; Barkati M
    Gynecol Oncol; 2021 Aug; 162(2):277-283. PubMed ID: 34059350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accuracy of 18-fluoro-2-deoxy-D-glucose positron emission tomography in the pretherapeutic detection of occult para-aortic node involvement in patients with a locally advanced cervical carcinoma.
    Leblanc E; Gauthier H; Querleu D; Ferron G; Zerdoud S; Morice P; Uzan C; Lumbroso S; Lecuru F; Bats AS; Ghazzar N; Bannier M; Houvenaeghel G; Brenot-Rossi I; Narducci F
    Ann Surg Oncol; 2011 Aug; 18(8):2302-9. PubMed ID: 21347790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer.
    Tangjitgamol S; Katanyoo K; Laopaiboon M; Lumbiganon P; Manusirivithaya S; Supawattanabodee B
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010401. PubMed ID: 25470408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning applied to MRI evaluation for the detection of lymph node metastasis in patients with locally advanced cervical cancer treated with neoadjuvant chemotherapy.
    Arezzo F; Cormio G; Mongelli M; Cazzato G; Silvestris E; Kardhashi A; Cazzolla A; Lombardi C; Venerito V; Loizzi V
    Arch Gynecol Obstet; 2023 Jun; 307(6):1911-1919. PubMed ID: 36370209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study.
    Ferrandina G; Palluzzi E; Gallotta V; Gambacorta MA; Autorino R; Turco LC; Macchia G; Cosentino F; Gui B; Mattoli MV; Ronzino G; Valentini V; Scambia G
    Eur J Surg Oncol; 2018 Jul; 44(7):1062-1068. PubMed ID: 29753611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-treatment surgical para-aortic lymph node assessment in locally advanced cervical cancer.
    Brockbank E; Kokka F; Bryant A; Pomel C; Reynolds K
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD008217. PubMed ID: 23543561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pre-treatment prediction of early response to chemoradiotherapy by quantitative analysis of baseline staging FDG-PET/CT and MRI in locally advanced cervical cancer.
    Min LA; Ackermans LL; Nowee ME; Griethuysen JJV; Roberti S; Maas M; Vogel WV; Beets-Tan RG; Lambregts DM
    Acta Radiol; 2021 Jul; 62(7):940-948. PubMed ID: 32722967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. False negative rate at
    Gouy S; Seebacher V; Chargari C; Terroir M; Grimaldi S; Ilenko A; Maulard A; Genestie C; Leary A; Pautier P; Morice P; Deandreis D
    BMC Cancer; 2021 Feb; 21(1):135. PubMed ID: 33549033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perioperative treatments for stage IB-IIB uterine cervical cancer.
    Shimada M; Tokunaga H; Kobayashi H; Ishikawa M; Yaegashi N
    Jpn J Clin Oncol; 2020 Feb; 50(2):99-103. PubMed ID: 31868879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined pretreatment with
    Ji S; Hu Q; Zhu J; Chen J; Chen Q; Liu Z; Shen C; Yang R; Sun H; Wu J; Gu K
    Trials; 2018 Aug; 19(1):416. PubMed ID: 30075736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tailored radical hysterectomy for locally advanced cervical cancer.
    Sakuragi N; Kaneuchi M; Kato T; Shimada C; Todo Y; Ihira K; Nozaki A; Umazume T; Konno Y; Mitamura T; Kobayashi N; Murakami G; Watari H
    Int J Gynecol Cancer; 2020 Aug; 30(8):1136-1142. PubMed ID: 32522774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Debulking hysterectomy followed by chemoradiotherapy versus chemoradiotherapy for FIGO stage (2019) IB3/II cervical cancer.
    Chakrabarti M; Nordin A; Khodabocus J
    Cochrane Database Syst Rev; 2022 Sep; 9(9):CD012246. PubMed ID: 36111784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The upper limit of optimal tumor size in patients with FIGO 2018 stage IB2 cervical cancer undergoing radical hysterectomy.
    Hwang WY; Kim JH; Suh DH; Kim K; No JH; Kim YB
    Int J Gynecol Cancer; 2020 Jul; 30(7):975-980. PubMed ID: 32467336
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is there a role for postoperative treatment in patients with stage Ib2-IIb cervical cancer treated with neo-adjuvant chemotherapy and radical surgery? An Italian multicenter retrospective study.
    Landoni F; Sartori E; Maggino T; Zola P; Zanagnolo V; Cosio S; Ferrari F; Piovano E; Gadducci A
    Gynecol Oncol; 2014 Mar; 132(3):611-7. PubMed ID: 24342439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.